|Articles|January 12, 2021 (Updated: January 14, 2021)
- Pharmaceutical Executive-01-01-2021
- Volume 41
- Issue 1
Pharmaceutical Executive, January 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
2021 in Focus: Pharm Exec’s Annual Industry Outlookabout 5 years ago
‘Breakthrough’ Balancing Act: The Decline of the Value Propositionabout 5 years ago
Prescriber Hesitancy on COVID Vaccinesabout 5 years ago
More Cloud on the Horizon for Pharmaabout 5 years ago
A New Year for Sustainable Governanceabout 5 years ago
Bound By Bloodabout 5 years ago
Pharma in Spotlight as Pandemic Continues in 2021about 5 years ago
Six Degrees of 2020about 5 years ago
Why Investing in Tech Education Is Importantabout 5 years ago
Pharm Exec Hits 40Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5

